Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: A systematic review and meta-analysis

European Respiratory Journal

Volumn 37, Issue 1, 2011, Pages 88-99

  Diel, R ^a   Goletti, D ^b   Ferrara, G ^c   Bothamley, G ^d   Cirillo, D ^e   Kampmann, B ^f   Lange, C ^g   Losi, M ^h   Markova, R ⁱ   Migliori, G B ^j   Nienhaus, A ^k   Ruhwald, M ^l   Wagner, D ^m   Zellweger, J P ⁿ   Huitric, E ^o   Sandgren, A ^o   Manissero, D ^o  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g RESEARCH CENTER BORSTEL   (Germany)

^h UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

ⁱ NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

^j WHO Collaborating Centre for Tuberculosis and Lung Diseases   (Italy)

^k UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^l UNIVERSITY OF COPENHAGEN   (Denmark)

^m UNIVERSITY OF FREIBURG   (Germany)

ⁿ UNIVERSITY OF LAUSANNE   (Switzerland)

^o EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

more..

Author keywords

ECDC; Interferon release assay; Latent mycobacterium tuberculosis infection; Meta analysis; Systematic review; TBNET

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; BCG VACCINATION; CHILD; COCHRANE LIBRARY; COMPARATIVE STUDY; DATA BASE; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; EMBASE; HUMAN; IMMUNOASSAY; IMMUNOCOMPETENCE; LUNG TUBERCULOSIS; MEDLINE; META ANALYSIS; MYCOBACTERIOSIS; MYCOBACTERIUM; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; RELIABILITY; SERODIAGNOSIS; SYSTEMATIC REVIEW; TASK PERFORMANCE; TUBERCULIN TEST;

ALGORITHMS; BCG VACCINE; CLINICAL TRIALS AS TOPIC; HUMANS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MULTIVARIATE ANALYSIS; MYCOBACTERIUM INFECTIONS; MYCOBACTERIUM TUBERCULOSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

EID: 79251547359     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00115110     Document Type: Article

References (82)

1. Raviglione MC, Uplekar MW. WHO's new Stop TB Strategy. Lancet 2006; 367: 952-955.
2. European Centre for Disease Prevention and Control. Framework Action Plan to Fight Tuberculosis in the European Union. www.ecdc.europa.eu/en/ publications/Publications/0803-SPR-TB-Action-plan.pdf Date last accessed: July 7, 2010. Date last updated: 2008.
3. Leung CC, Rieder HL, Lange C, et al. Treatment of latent infection with M. tuberculosis: update 2010. Eur Respir J 2010; [Epub ahead of print DOI: 10.1183/?09031936.00079310].
4. Bothamley GH, Ditiu L, Migliori GB, et al. Active case finding of tuberculosis in Europe: a Tuberculosis Network European Trials Group (TBNET) survey. Eur Respir J 2008; 32: 1023-1030.
5. Erkens C, Kamphorst M, Abubakar I, et al. Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur Respir J 2010; 36: 925-949.
6. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161: S221-S247.
7. Andersen P, Munk ME, Pollock JM, et al. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356: 1099-1104.
8. Cellestis. QuantiFERON1-TB Gold. www.cellestis.com/IRM/content/aust/ qtfproducts-tbgoldintube.html Date last accessed: October 29, 2010. Date last updated: 2009.
9. OxfordImmunotec. T.SPOT®.TB. www.oxfordimmunotec.com/T-SPOT.TB- International Date last accessed: October 29, 2010. Date last updated: 2009.
10. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149: 177-184.
11. Mack U, Migliori GB, Sester M, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009; 33: 956-973.
12. The National Collaborating Centre for Chronic Conditions. Tuberculosis. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London, Royal College of Physicians, 2006.
13. Mazurek GH, Jereb J, Lobue P, et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54: 49-55.
14. Solovic I, Sester M, Gomez-Reino JJ, et al. The risk of tuberculosis related to TNF antagonist therapies: a TBNET consensus statement. Eur Respir J 2010; 36: 1185-1206.
15. Lange C, Pai M, Drobniewski F, et al. Interferon-γ release assays for the diagnosis of active tuberculosis: sensible or silly? Eur Respir J 2009; 33: 1250-1253.
16. Chang KC, Leung CC. Systematic review of interferon-γ release assays in tuberculosis: focus on likelihood ratios. Thorax 2010; 65: 271-276.
17. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-354.
18. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
19. Aichelburg MC, Rieger A, Breitenecker F, et al. Detection and prediction of active tuberculosis disease by a whole-blood interferon-γ release assay in HIV-1-infected individuals. Clin Infect Dis 2009; 48: 954-962.
20. Diel R, Loddenkemper R, Meywald-Walter K, et al. Predictive value of a whole blood IFN-γ assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008; 177: 1164-1170.
21. Kik SV, Franken WP, Mensen M, et al. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J 2010; 35: 1346-1353.
22. Clark SA, Martin SL, Pozniak A, et al. Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol 2007; 150: 238-244.
23. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
24. Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: 25.
25. Zamora J, Abraira V, Muriel A, et al. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006; 6: 31. (Pubitemid 44285240)
26. Detjen AK, Keil T, Roll S, et al. Interferon-γ release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007; 45: 322-328.
27. Franken WP, Timmermans JF, Prins C, et al. Comparison of Mantoux and QuantiFERON TB Gold tests for diagnosis of latent tuberculosis infection in Army personnel. Clin Vaccine Immunol 2007; 14: 477-480.
28. Palazzo R, Spensieri F, Massari M, et al. Use of whole-blood samples in in-house bulk and single-cell antigen-specific gamma interferon assays for surveillance of Mycobacterium tuberculosis infections. Clin Vaccine Immunol 2008; 15: 327-337.
29. Ruhwald M, Petersen J, Kofoed K, et al. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS ONE 2008; 3: e2858.
30. Bienek DR, Chang CK. Evaluation of an interferon-γ release assay, T-SPOT.TB, in a population with a low prevalence of tuberculosis. Int J Tuberc Lung Dis 2009; 13: 1416-1421.
31. Harada N, Higuchi K, Yoshiyama T, et al. Comparison of the sensitivity and specificity of two whole blood interferon-γ assays for M. tuberculosis infection. J Infect 2008; 56: 348-353.
32. Higuchi K, Kawabe Y, Mitarai S, et al. Comparison of performance in two diagnostic methods for tuberculosis infection. Med Microbiol Immunol 2009; 198: 33-37.
33. Lee JY, Choi HJ, Park IN, et al. Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006; 28: 24-30.
34. Dheda K, van Zyl-Smit RN, Meldau R, et al. Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis. Thorax 2009; 64: 847-853.
35. Goletti D, Vincenti D, Carrara S, et al. Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clin Diagn Lab Immunol 2005; 12: 1311-1316. (Pubitemid 41626601)
36. Goletti D, Carrara S, Butera O, et al. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study. PLoS ONE 2008; 3: e3417.
37. Jafari C, Ernst M, Kalsdorf B, et al. Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. Am J Respir Crit Care Med 2006; 174: 1048-1054.
38. Jafari C, Thijsen S, Sotgiu G, et al. Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trials group study. Am J Respir Crit Care Med 2009; 180: 666-673.
39. Kampmann B, Whittaker E, Williams A, et al. Interferon-γ release assays do not identify more children with active tuberculosis than the tuberculin skin test. Eur Respir J 2009; 33: 1374-1382.
40. Kang YA, Lee HW, Hwang SS, et al. Usefulness of whole-blood interferon-γ assay and interferon-γ enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 2007; 132: 959-965.
41. Lee LN, Chou CH, Wang JY, et al. Enzyme-linked immunospot assay for interferon-γ in the diagnosis of tuberculous pleurisy. Clin Microbiol Infect 2009; 15: 173-179.
42. Markova R, Todorova Y, Drenska R, et al. Usefulness of interferon-γ release assays in the diagnosis of tuberculosis infection in HIV-infected patients in Bulgaria. Biotechnol Biotechnol Eq 2009; 23: 1103-1108.
43. Wang JY, Chou CH, Lee LN, et al. Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-γ. Emerg Infect Dis 2007; 13: 553-558.
44. Baba K, Sornes S, Hoosen AA, et al. Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON TB-Gold interferon-γ assay. BMC Infect Dis 2008; 8: 35.
45. Silverman MS, Reynolds D, Kavsak PA, et al. Use of an interferon-γ based assay to assess bladder cancer patients treated with intravesical BCG and exposed to tuberculosis. Clin Biochem 2007; 40: 913-915.
46. Lee SS, Chou KJ, Su IJ, et al. High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. Infection 2009; 37: 96-102.
47. Diel R, Nienhaus A, Lange C, et al. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir Res 2006; 7: 77.
48. Zellweger JP, Zellweger A, Ansermet S, et al. Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test. Int J Tuberc Lung Dis 2005; 9: 1242-1247. (Pubitemid 41735604)
49. Alvarez-Leon EE, Espinosa-Vega E, Santana-Rodriguez E, et al. Screening for tuberculosis infection in spanish healthcare workers: comparison of the QuantiFERON-TB Gold in-tube test with the tuberculin skin test. Infect Control Hosp Epidemiol 2009; 30: 876-883.
50. Bartalesi F, Vicidomini S, Goletti D, et al. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases. Eur Respir J 2009; 33: 586-593.
51. Bianchi L, Galli L, Moriondo M, et al. Interferon-γ release assay improves the diagnosis of tuberculosis in children. Pediatr Infect Dis J 2009; 28: 510-514.
52. Brodie D, Lederer DJ, Gallardo JS, et al. Use of an interferon-γ release assay to diagnose latent tuberculosis infection in foreignborn patients. Chest 2008; 133: 869-874. (Pubitemid 351551811)
53. Casas I, Latorre I, Esteve M, et al. Evaluation of interferon-γ release assays in the diagnosis of recent tuberculosis infection in health care workers. PLoS One 2009; 4: e6686.
54. Chun JK, Kim CK, Kim HS, et al. The role of a whole blood interferon-γ assay for the detection of latent tuberculosis infection in Bacille Calmette-Guerin vaccinated children. Diagn Microbiol Infect Dis 2008; 62: 389-394.
55. Chung WK, Zheng ZL, Sung JY, et al. Validity of interferon-γ- release assays for the diagnosis of latent tuberculosis in haemodialysis patients. Clin Microbiol Infect 2010; 16: 960-965.
56. Dogra S, Narang P, Mendiratta DK, et al. Comparison of a whole blood interferon-γ assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J Infect 2007; 54: 267-276.
57. Dominguez J, Ruiz-Manzano J, De Souza-Galvao M, et al. Comparison of two commercially available gamma interferon blood tests for immunodiagnosis of tuberculosis. Clin Vaccine Immunol 2008; 15: 168-171.
58. Goletti D, Carrara S, Vincenti D, et al. Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study. Clin Microbiol Infect 2006; 12: 544-550.
59. Hansted E, Andriuskeviciene A, Sakalauskas R, et al. T-cell-based diagnosis of tuberculosis infection in children in Lithuania: a country of high incidence despite a high coverage with bacille Calmette-Guerin vaccination. BMC Pulm Med 2009; 9: 41.
60. Herrmann JL, Simonney N, Bergeron A, et al. IFNγ and antibody responses among French nurses during a tuberculosis contact tracing investigation. Pathol Biol (Paris) 2009; 57: e49-e53.
61. Hesseling AC, Mandalakas AM, Kirchner HL, et al. Highly discordant T cell responses in individuals with recent exposure to household tuberculosis. Thorax 2009; 64: 840-846.
62. Janssens JP, Roux-Lombard P, Perneger T, et al. Contribution of a IFN-γ assay in contact tracing for tuberculosis in a low-incidence, high immigration area. Swiss Med Wkly 2008; 138: 585-593.
63. Kariminia A, Sharifnia Z, Aghakhani A, et al. Comparison of QuantiFERON TB-G-test to TST for detecting latent tuberculosis infection in a high-incidence area containing BCG-vaccinated population. J Eval Clin Pract 2009; 15: 148-151.
64. Laffitte E, Janssens JP, Roux-Lombard P, et al. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-γ release assay vs. tuberculin skin test. Brit J Dermatol 2009; 161: 797-800.
65. Lien LT, Hang NT, Kobayashi N, et al. Prevalence and risk factors for tuberculosis infection among hospital workers in Hanoi, Viet Nam. PLoS One 2009; 4: e6798.
66. Manuel O, Humar A, Preiksaitis J, et al. Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant 2007; 7: 2797-2801.
67. Matulis G, Juni P, Villiger PM, et al. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay. Ann Rheum Dis 2008; 67: 84-90.
68. Ozekinci T, Ozbek E, Celik Y. Comparison of tuberculin skin test and a specific T-cell-based test, T-Spot.TB, for the diagnosis of latent tuberculosis infection. J Int Med Res 2007; 35: 696-703. (Pubitemid 47570491)
69. Perry S, Sanchez L, Yang S, et al. Reproducibility of QuantiFERON-TB gold in-tube assay. Clin Vaccine Immunol 2008; 15: 425-432. (Pubitemid 351967072)
70. Porsa E, Cheng L, Graviss EA. Comparison of an ESAT-6/CFP-10 peptide-based enzyme-linked immunospot assay to a tuberculin skin test for screening of a population at moderate risk of contracting tuberculosis. Clin Vaccine Immunol 2007; 14: 714-719.
71. Ringshausen FC, Schlosser S, Nienhaus A, et al. In-hospital contact investigation among health care workers after exposure to smear-negative tuberculosis. J Occup Med Toxicol 2009; 4: 11.
72. Seyhan EC, Sokucu S, Altin S, et al. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients. Transpl Infect Dis 2010; 12: 98-105.
73. Soysal A, Turel O, Toprak D, et al. Comparison of positive tuberculin skin test with an interferon-γ-based assay in unexposed children. Jpn J Infect Dis 2008; 61: 192-195.
74. Triverio PA, Bridevaux PO, Roux-Lombard P, et al. Interferon-γ release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol Dial Transplant 2009; 24: 1952-1956.
75. Tsiouris SJ, Coetzee D, Toro PL, et al. Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol 2006; 44: 2844-2850.
76. Vassilopoulos D, Stamoulis N, Hadziyannis E, et al. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. J Rheumatol 2008; 35: 1271-1276. (Pubitemid 352000770)
77. Vinton P, Mihrshahi S, Johnson P, et al. Comparison of QuantiFERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection. Infect Control Hosp Epidemiol 2009; 30: 215-221.
78. Goletti D, Butera O, Vanini V, et al. Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection. Eur Respir J 2010; 36: 135-142.
79. Ferrara G, Losi M, D'Amico R, et al. Interferon-γ-release assays detect recent tuberculosis re-infection in elderly contacts. Int J Immunopathol Pharmacol 2009; 22: 669-677.
80. Chee CB, KhinMar KW, Gan SH, et al. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens. Am J Respir Crit Care Med 2007; 175: 282-287.
81. van Zyl-Smit RN, Pai M, Peprah K, et al. Within-subject variability and boosting of T-cell interferon-γ responses after tuberculin skin testing. Am J Respir Crit Care Med 2009; 180: 49-58.
82. Krummel B, Strassburg A, Ernst M, et al. Potential role for IL-2 ELISpot in differentiating recent and remote infection in tuberculosis contact tracing. PloS ONE 2010; 5: e11670.